BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36056891)

  • 1. Should Linezolid Replace Clindamycin as the Adjunctive Antimicrobial of Choice in Group A Streptococcal Necrotizing Soft Tissue Infection and Toxic Shock Syndrome? A Focused Debate.
    Cortés-Penfield N; Ryder JH
    Clin Infect Dis; 2023 Jan; 76(2):346-350. PubMed ID: 36056891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rare presentation of necrotising fasciitis and streptococcal toxic shock syndrome by group A streptococcus.
    Saeed S; Alothman S; Ahmed L; Donaldson B
    BMJ Case Rep; 2017 Sep; 2017():. PubMed ID: 28954758
    [No Abstract]   [Full Text] [Related]  

  • 3. Effectiveness of adjunctive clindamycin in β-lactam antibiotic-treated patients with invasive β-haemolytic streptococcal infections in US hospitals: a retrospective multicentre cohort study.
    Babiker A; Li X; Lai YL; Strich JR; Warner S; Sarzynski S; Dekker JP; Danner RL; Kadri SS
    Lancet Infect Dis; 2021 May; 21(5):697-710. PubMed ID: 33333013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between adjunct clindamycin and in-hospital mortality in patients with necrotizing soft tissue infection due to group A Streptococcus: a nationwide cohort study.
    Hamada S; Nakajima M; Kaszynski RH; Otaka S; Goto H; Matsui H; Fushimi K; Yamaguchi Y; Yasunaga H
    Eur J Clin Microbiol Infect Dis; 2022 Feb; 41(2):263-270. PubMed ID: 34755257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Toxic shock-like syndrome caused by streptococci].
    van Dissel JT; Kullberg BJ; van der Meer JW
    Ned Tijdschr Geneeskd; 1999 Jul; 143(28):1452-5. PubMed ID: 10443259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly virulent M1 Streptococcus pyogenes isolates resistant to clindamycin.
    Plainvert C; Martin C; Loubinoux J; Touak G; Dmytruk N; Collobert G; Fouet A; Ploy MC; Poyart C
    Med Mal Infect; 2015; 45(11-12):470-4. PubMed ID: 26602794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group a streptococcal infections.
    Carapetis JR; Jacoby P; Carville K; Ang SJ; Curtis N; Andrews R
    Clin Infect Dis; 2014 Aug; 59(3):358-65. PubMed ID: 24785239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment.
    Stevens DL
    Emerg Infect Dis; 1995; 1(3):69-78. PubMed ID: 8903167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clindamycin Affects Group A Streptococcus Virulence Factors and Improves Clinical Outcome.
    Andreoni F; Zürcher C; Tarnutzer A; Schilcher K; Neff A; Keller N; Marques Maggio E; Poyart C; Schuepbach RA; Zinkernagel AS
    J Infect Dis; 2017 Jan; 215(2):269-277. PubMed ID: 27247345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infections due to group A streptococcus: new concepts and potential treatment strategies.
    Norrby SR; Norrby-Teglund A
    Ann Acad Med Singap; 1997 Sep; 26(5):691-3. PubMed ID: 9494680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive group A streptococcal disease.
    Stevens DL
    Infect Agents Dis; 1996 Jun; 5(3):157-66. PubMed ID: 8805078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive antibiotic therapy with clindamycin or linezolid in patients with group A streptococcus (GAS) meningitis.
    Rezahosseini O; Roed C; Gitz Holler J; Frimodt-Møller N; Harboe ZB
    Infect Dis (Lond); 2023 Oct; 55(10):751-753. PubMed ID: 37415443
    [No Abstract]   [Full Text] [Related]  

  • 13. Non-Necrotizing Soft Tissue Infection and Streptococcal Toxic Shock Syndrome Caused by a Novel Streptococcus pyogenes Subtype (emm76.10).
    Hashiyama T; Mori N; Fukushima Y; Takahashi T
    Jpn J Infect Dis; 2020 Sep; 73(5):373-376. PubMed ID: 32350222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retiform Purpura as a Sign of Necrotizing Cellulitis in an Immunocompetent Boy.
    Aboul-Fettouh N; Nguyen KD; Dominguez AR
    Pediatr Emerg Care; 2020 Nov; 36(11):e646-e648. PubMed ID: 32970024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro pharmacokinetic/pharmacodynamic activity of NXL103 versus clindamycin and linezolid against clinical Staphylococcus aureus and Streptococcus pyogenes isolates.
    Vidaillac C; Parra-Ruiz J; Winterfield P; Rybak MJ
    Int J Antimicrob Agents; 2011 Oct; 38(4):301-6. PubMed ID: 21764263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clindamycin in the treatment of streptococcal and staphylococcal toxic shock syndromes.
    Russell NE; Pachorek RE
    Ann Pharmacother; 2000; 34(7-8):936-9. PubMed ID: 10928407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of β-Hemolytic Streptococcal Necrotizing Skin and Soft-tissue Infections and the Impact of Clindamycin Resistance.
    Horn DL; Roberts EA; Shen J; Chan JD; Bulger EM; Weiss NS; Lynch JB; Bryson-Cahn C; Robinson BRH
    Clin Infect Dis; 2021 Dec; 73(11):e4592-e4598. PubMed ID: 33151283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Toxic shock-like syndrome caused by streptococci--treated with clindamycin].
    Nørgaard M
    Ugeskr Laeger; 1997 Apr; 159(16):2396-7. PubMed ID: 9163118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Necrotizing soft tissue infections caused by Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis of groups C and G in western Norway.
    Bruun T; Kittang BR; de Hoog BJ; Aardal S; Flaatten HK; Langeland N; Mylvaganam H; Vindenes HA; Skrede S
    Clin Microbiol Infect; 2013 Dec; 19(12):E545-50. PubMed ID: 23795951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Beta-hemolytic streptococcal bacteremia in adults].
    Rantala S
    Duodecim; 2013; 129(14):1477-84. PubMed ID: 23961606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.